European Archives - Page 109 of 1139 - European Medical Journal

Mitochondrial Dysfunction Linked to Diabetes, Study Finds

Mitochondria dysfunction has been found to be involved in the development of diabetes in newly published research.

Peanut Oral Immunotherapy Shows Promise for Allergy Treatment

A recent study investigated the efficacy of peanut oral immunotherapy using home-measured peanut butter compared to strict peanut avoidance in children.

Clinical Complete Response a New Prognostic Marker in Liver Cancer

cCR predicts survival outcomes in unresectable hepatocellular carcinoma, providing a valuable marker for treatment response and prognosis.

Reusable Menstrual Products May Lead to Missed Heavy Bleeding Diagnoses

Reusable menstrual products require fewer changes but cause more leaks, potentially affecting heavy menstrual bleeding diagnosis.

Fewer Gout Flares and Improved Lipid Profile Seen with Urine Alkalization Therapy

A new study revealed that adding urine alkalization therapy to febuxostat treatment in gout patients with low urinary pH leads to fewer flares, improved kidney health, and better lipid profiles.

AI-Enhanced Spectroscopy Reveals Environmental Toxins in Human Placenta

Machine learning-enhanced spectroscopy rapidly detects harmful toxins in the placenta, improving maternal-foetal health monitoring and clinical diagnostics.

Kennedy secures US health role despite backlash

Robert F. Kennedy Jr has been confirmed as the US Secretary of Health and Human Services following a 52-48 Senate vote.

Carbapenem-Resistant Infections Rising Across Europe

Carbapenem-resistant Enterobacterales infections are on the rise across Europe, with experts warning of worsening transmission and increasing resistance.

Ulcerative Colitis and Clostridioides difficile: New Insights into Infection Risk

A new study highlights that IBD patients, especially those with ulcerative colitis, are at significantly higher risk of Clostridioides difficile infection (CDI).

Neoadjuvant T-VEC Shows Promise for Difficult-to-Treat Basal Cell Carcinoma

Neoadjuvant T-VEC achieves resectability in 50% of difficult-to-treat BCC cases, improving outcomes without extensive reconstructive surgery.